179 FEASIBILITY AND ONCOLOGICAL OUTCOME OF CHEMORADIATION WITH INTENSIFIED IMRT IN LOCALLY ADVANCED ESOPHAGEAL CANCER
Abstract To assess safety, feasibility and efficacy of an intensified preoperative IMRT and concomitant carboplatin and paclitaxel-based chemotherapy (Carbo/Tax CT) in patients (pts) with locally advanced esophageal cancer (LAEC) treated at our Institution. Methods a retrospective analysis of toxi...
Gespeichert in:
| Veröffentlicht in: | Diseases of the esophagus 2020-09, Vol.33 (Supplement_1) |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | Supplement_1 |
| container_start_page | |
| container_title | Diseases of the esophagus |
| container_volume | 33 |
| creator | Innocente, R Navarria, F Petri, R Palazzari, E Gigante, M Vecchiato, M Ziccarelli, A Martino, A Foltran, L Buonadonna, A Lo Re, G Spina, M Ubiali, P Tonin, D Lauretta, A Polesel, J Franchin, G De Paoli, A |
| description | Abstract
To assess safety, feasibility and efficacy of an intensified preoperative IMRT and concomitant carboplatin and paclitaxel-based chemotherapy (Carbo/Tax CT) in patients (pts) with locally advanced esophageal cancer (LAEC) treated at our Institution.
Methods
a retrospective analysis of toxicity (CTCAE 4.03), progression free survival (PFS) and overall survival (OS) of pts affected by LAEC, treated with preoperative intensified radiotherapy (IMRT) and weekly concurrent carboplatin and paclitaxel-based chemotherapy (CT) according to the CROSS trial, between February 2016 and October 2019, at the Centro di Riferimento Oncologico, Aviano (CRO).
Results
Sixty-nine consecutive pts, 57(82.6%) males, were treated. The median age was 69 yrs (38–85), the ECOG PS 0–2. All pts underwent concurrent chemoradiotherapy, IMRT technique, 45 Gy/25 to PTV1 (primary tumor volume + regional nodes), a simultaneous boost from 52.5Gy to 54Gy to PTV2 (gross tumor volume) and weekly concurrent carboplatin (AUC2) and paclitaxel (50 mg/m2). Induction CT was administered to 17 pts. All pts completed RT with median 4 (1–5) CT cycles. Median follow-up was 8 months (4–17); 2-yr PFS and OS were 49.0% and 80.3%, respectively. At 2 yrs, local recurrence rate was 8.4% (CI 95%: 2.6%–18.8%).
Conclusion
Preoperative intensified IMRT with concomitant Carbo/Tax CT in pts with LAEC appears safe and feasible with promising oncological outcome and needs to be confirmed in a larger series of pts.
Characteristic, toxicity and result |
| doi_str_mv | 10.1093/dote/doaa087.34 |
| format | Article |
| fullrecord | <record><control><sourceid>oup_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_dote_doaa087_34</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/dote/doaa087.34</oup_id><sourcerecordid>10.1093/dote/doaa087.34</sourcerecordid><originalsourceid>FETCH-LOGICAL-c754-4d0c88716d42a038a66c68ed2b8226e994a134aa1d3a6ab02bb4d48e745c7c323</originalsourceid><addsrcrecordid>eNqFkM1LAzEQxYMoWKtnrzkL2-arSfYYs9luYLuRNiqeluxHQVFadu2h_70p7d3LzPBm3hv4AfCI0QyjlM673W8fSwhIihllV2CCGSMJQQt0HWdMUCJ5ym7B3Th-IYQF5XICDlikMDdqY59taf0HVFUGXaVd6ZZWqxK6V6_dykCXQ12YlVurzCpvXQXfrS-grbypNja3JoN2tfZRgKWLxjJGZW-q0nFhNu6lUEsT4_RJWd-Dm234HvuHS58Cnxuvi-TyNWnFgiWsQ62UAvOOkYCoDJy3XPYdaSQhvE9TFjBlIeCOBh4aRJqGdUz2gi1a0VJCp2B-jm2H3TgO_bbeD58_YTjWGNUnaPUJWn2BVlMWHU9nx-6w__f4D3zWZa0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>179 FEASIBILITY AND ONCOLOGICAL OUTCOME OF CHEMORADIATION WITH INTENSIFIED IMRT IN LOCALLY ADVANCED ESOPHAGEAL CANCER</title><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Innocente, R ; Navarria, F ; Petri, R ; Palazzari, E ; Gigante, M ; Vecchiato, M ; Ziccarelli, A ; Martino, A ; Foltran, L ; Buonadonna, A ; Lo Re, G ; Spina, M ; Ubiali, P ; Tonin, D ; Lauretta, A ; Polesel, J ; Franchin, G ; De Paoli, A</creator><creatorcontrib>Innocente, R ; Navarria, F ; Petri, R ; Palazzari, E ; Gigante, M ; Vecchiato, M ; Ziccarelli, A ; Martino, A ; Foltran, L ; Buonadonna, A ; Lo Re, G ; Spina, M ; Ubiali, P ; Tonin, D ; Lauretta, A ; Polesel, J ; Franchin, G ; De Paoli, A</creatorcontrib><description>Abstract
To assess safety, feasibility and efficacy of an intensified preoperative IMRT and concomitant carboplatin and paclitaxel-based chemotherapy (Carbo/Tax CT) in patients (pts) with locally advanced esophageal cancer (LAEC) treated at our Institution.
Methods
a retrospective analysis of toxicity (CTCAE 4.03), progression free survival (PFS) and overall survival (OS) of pts affected by LAEC, treated with preoperative intensified radiotherapy (IMRT) and weekly concurrent carboplatin and paclitaxel-based chemotherapy (CT) according to the CROSS trial, between February 2016 and October 2019, at the Centro di Riferimento Oncologico, Aviano (CRO).
Results
Sixty-nine consecutive pts, 57(82.6%) males, were treated. The median age was 69 yrs (38–85), the ECOG PS 0–2. All pts underwent concurrent chemoradiotherapy, IMRT technique, 45 Gy/25 to PTV1 (primary tumor volume + regional nodes), a simultaneous boost from 52.5Gy to 54Gy to PTV2 (gross tumor volume) and weekly concurrent carboplatin (AUC2) and paclitaxel (50 mg/m2). Induction CT was administered to 17 pts. All pts completed RT with median 4 (1–5) CT cycles. Median follow-up was 8 months (4–17); 2-yr PFS and OS were 49.0% and 80.3%, respectively. At 2 yrs, local recurrence rate was 8.4% (CI 95%: 2.6%–18.8%).
Conclusion
Preoperative intensified IMRT with concomitant Carbo/Tax CT in pts with LAEC appears safe and feasible with promising oncological outcome and needs to be confirmed in a larger series of pts.
Characteristic, toxicity and result</description><identifier>ISSN: 1120-8694</identifier><identifier>EISSN: 1442-2050</identifier><identifier>DOI: 10.1093/dote/doaa087.34</identifier><language>eng</language><publisher>Oxford University Press</publisher><ispartof>Diseases of the esophagus, 2020-09, Vol.33 (Supplement_1)</ispartof><rights>The Author(s) 2020. Published by Oxford University Press on behalf of International Society for Diseases of the Esophagus. 2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Innocente, R</creatorcontrib><creatorcontrib>Navarria, F</creatorcontrib><creatorcontrib>Petri, R</creatorcontrib><creatorcontrib>Palazzari, E</creatorcontrib><creatorcontrib>Gigante, M</creatorcontrib><creatorcontrib>Vecchiato, M</creatorcontrib><creatorcontrib>Ziccarelli, A</creatorcontrib><creatorcontrib>Martino, A</creatorcontrib><creatorcontrib>Foltran, L</creatorcontrib><creatorcontrib>Buonadonna, A</creatorcontrib><creatorcontrib>Lo Re, G</creatorcontrib><creatorcontrib>Spina, M</creatorcontrib><creatorcontrib>Ubiali, P</creatorcontrib><creatorcontrib>Tonin, D</creatorcontrib><creatorcontrib>Lauretta, A</creatorcontrib><creatorcontrib>Polesel, J</creatorcontrib><creatorcontrib>Franchin, G</creatorcontrib><creatorcontrib>De Paoli, A</creatorcontrib><title>179 FEASIBILITY AND ONCOLOGICAL OUTCOME OF CHEMORADIATION WITH INTENSIFIED IMRT IN LOCALLY ADVANCED ESOPHAGEAL CANCER</title><title>Diseases of the esophagus</title><description>Abstract
To assess safety, feasibility and efficacy of an intensified preoperative IMRT and concomitant carboplatin and paclitaxel-based chemotherapy (Carbo/Tax CT) in patients (pts) with locally advanced esophageal cancer (LAEC) treated at our Institution.
Methods
a retrospective analysis of toxicity (CTCAE 4.03), progression free survival (PFS) and overall survival (OS) of pts affected by LAEC, treated with preoperative intensified radiotherapy (IMRT) and weekly concurrent carboplatin and paclitaxel-based chemotherapy (CT) according to the CROSS trial, between February 2016 and October 2019, at the Centro di Riferimento Oncologico, Aviano (CRO).
Results
Sixty-nine consecutive pts, 57(82.6%) males, were treated. The median age was 69 yrs (38–85), the ECOG PS 0–2. All pts underwent concurrent chemoradiotherapy, IMRT technique, 45 Gy/25 to PTV1 (primary tumor volume + regional nodes), a simultaneous boost from 52.5Gy to 54Gy to PTV2 (gross tumor volume) and weekly concurrent carboplatin (AUC2) and paclitaxel (50 mg/m2). Induction CT was administered to 17 pts. All pts completed RT with median 4 (1–5) CT cycles. Median follow-up was 8 months (4–17); 2-yr PFS and OS were 49.0% and 80.3%, respectively. At 2 yrs, local recurrence rate was 8.4% (CI 95%: 2.6%–18.8%).
Conclusion
Preoperative intensified IMRT with concomitant Carbo/Tax CT in pts with LAEC appears safe and feasible with promising oncological outcome and needs to be confirmed in a larger series of pts.
Characteristic, toxicity and result</description><issn>1120-8694</issn><issn>1442-2050</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqFkM1LAzEQxYMoWKtnrzkL2-arSfYYs9luYLuRNiqeluxHQVFadu2h_70p7d3LzPBm3hv4AfCI0QyjlM673W8fSwhIihllV2CCGSMJQQt0HWdMUCJ5ym7B3Th-IYQF5XICDlikMDdqY59taf0HVFUGXaVd6ZZWqxK6V6_dykCXQ12YlVurzCpvXQXfrS-grbypNja3JoN2tfZRgKWLxjJGZW-q0nFhNu6lUEsT4_RJWd-Dm234HvuHS58Cnxuvi-TyNWnFgiWsQ62UAvOOkYCoDJy3XPYdaSQhvE9TFjBlIeCOBh4aRJqGdUz2gi1a0VJCp2B-jm2H3TgO_bbeD58_YTjWGNUnaPUJWn2BVlMWHU9nx-6w__f4D3zWZa0</recordid><startdate>20200914</startdate><enddate>20200914</enddate><creator>Innocente, R</creator><creator>Navarria, F</creator><creator>Petri, R</creator><creator>Palazzari, E</creator><creator>Gigante, M</creator><creator>Vecchiato, M</creator><creator>Ziccarelli, A</creator><creator>Martino, A</creator><creator>Foltran, L</creator><creator>Buonadonna, A</creator><creator>Lo Re, G</creator><creator>Spina, M</creator><creator>Ubiali, P</creator><creator>Tonin, D</creator><creator>Lauretta, A</creator><creator>Polesel, J</creator><creator>Franchin, G</creator><creator>De Paoli, A</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20200914</creationdate><title>179 FEASIBILITY AND ONCOLOGICAL OUTCOME OF CHEMORADIATION WITH INTENSIFIED IMRT IN LOCALLY ADVANCED ESOPHAGEAL CANCER</title><author>Innocente, R ; Navarria, F ; Petri, R ; Palazzari, E ; Gigante, M ; Vecchiato, M ; Ziccarelli, A ; Martino, A ; Foltran, L ; Buonadonna, A ; Lo Re, G ; Spina, M ; Ubiali, P ; Tonin, D ; Lauretta, A ; Polesel, J ; Franchin, G ; De Paoli, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c754-4d0c88716d42a038a66c68ed2b8226e994a134aa1d3a6ab02bb4d48e745c7c323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Innocente, R</creatorcontrib><creatorcontrib>Navarria, F</creatorcontrib><creatorcontrib>Petri, R</creatorcontrib><creatorcontrib>Palazzari, E</creatorcontrib><creatorcontrib>Gigante, M</creatorcontrib><creatorcontrib>Vecchiato, M</creatorcontrib><creatorcontrib>Ziccarelli, A</creatorcontrib><creatorcontrib>Martino, A</creatorcontrib><creatorcontrib>Foltran, L</creatorcontrib><creatorcontrib>Buonadonna, A</creatorcontrib><creatorcontrib>Lo Re, G</creatorcontrib><creatorcontrib>Spina, M</creatorcontrib><creatorcontrib>Ubiali, P</creatorcontrib><creatorcontrib>Tonin, D</creatorcontrib><creatorcontrib>Lauretta, A</creatorcontrib><creatorcontrib>Polesel, J</creatorcontrib><creatorcontrib>Franchin, G</creatorcontrib><creatorcontrib>De Paoli, A</creatorcontrib><collection>CrossRef</collection><jtitle>Diseases of the esophagus</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Innocente, R</au><au>Navarria, F</au><au>Petri, R</au><au>Palazzari, E</au><au>Gigante, M</au><au>Vecchiato, M</au><au>Ziccarelli, A</au><au>Martino, A</au><au>Foltran, L</au><au>Buonadonna, A</au><au>Lo Re, G</au><au>Spina, M</au><au>Ubiali, P</au><au>Tonin, D</au><au>Lauretta, A</au><au>Polesel, J</au><au>Franchin, G</au><au>De Paoli, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>179 FEASIBILITY AND ONCOLOGICAL OUTCOME OF CHEMORADIATION WITH INTENSIFIED IMRT IN LOCALLY ADVANCED ESOPHAGEAL CANCER</atitle><jtitle>Diseases of the esophagus</jtitle><date>2020-09-14</date><risdate>2020</risdate><volume>33</volume><issue>Supplement_1</issue><issn>1120-8694</issn><eissn>1442-2050</eissn><abstract>Abstract
To assess safety, feasibility and efficacy of an intensified preoperative IMRT and concomitant carboplatin and paclitaxel-based chemotherapy (Carbo/Tax CT) in patients (pts) with locally advanced esophageal cancer (LAEC) treated at our Institution.
Methods
a retrospective analysis of toxicity (CTCAE 4.03), progression free survival (PFS) and overall survival (OS) of pts affected by LAEC, treated with preoperative intensified radiotherapy (IMRT) and weekly concurrent carboplatin and paclitaxel-based chemotherapy (CT) according to the CROSS trial, between February 2016 and October 2019, at the Centro di Riferimento Oncologico, Aviano (CRO).
Results
Sixty-nine consecutive pts, 57(82.6%) males, were treated. The median age was 69 yrs (38–85), the ECOG PS 0–2. All pts underwent concurrent chemoradiotherapy, IMRT technique, 45 Gy/25 to PTV1 (primary tumor volume + regional nodes), a simultaneous boost from 52.5Gy to 54Gy to PTV2 (gross tumor volume) and weekly concurrent carboplatin (AUC2) and paclitaxel (50 mg/m2). Induction CT was administered to 17 pts. All pts completed RT with median 4 (1–5) CT cycles. Median follow-up was 8 months (4–17); 2-yr PFS and OS were 49.0% and 80.3%, respectively. At 2 yrs, local recurrence rate was 8.4% (CI 95%: 2.6%–18.8%).
Conclusion
Preoperative intensified IMRT with concomitant Carbo/Tax CT in pts with LAEC appears safe and feasible with promising oncological outcome and needs to be confirmed in a larger series of pts.
Characteristic, toxicity and result</abstract><pub>Oxford University Press</pub><doi>10.1093/dote/doaa087.34</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1120-8694 |
| ispartof | Diseases of the esophagus, 2020-09, Vol.33 (Supplement_1) |
| issn | 1120-8694 1442-2050 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_dote_doaa087_34 |
| source | Oxford University Press Journals All Titles (1996-Current) |
| title | 179 FEASIBILITY AND ONCOLOGICAL OUTCOME OF CHEMORADIATION WITH INTENSIFIED IMRT IN LOCALLY ADVANCED ESOPHAGEAL CANCER |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T19%3A44%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=179%20FEASIBILITY%20AND%20ONCOLOGICAL%20OUTCOME%20OF%20CHEMORADIATION%20WITH%20INTENSIFIED%20IMRT%20IN%20LOCALLY%20ADVANCED%20ESOPHAGEAL%20CANCER&rft.jtitle=Diseases%20of%20the%20esophagus&rft.au=Innocente,%20R&rft.date=2020-09-14&rft.volume=33&rft.issue=Supplement_1&rft.issn=1120-8694&rft.eissn=1442-2050&rft_id=info:doi/10.1093/dote/doaa087.34&rft_dat=%3Coup_cross%3E10.1093/dote/doaa087.34%3C/oup_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_oup_id=10.1093/dote/doaa087.34&rfr_iscdi=true |